TNF-α and TNF-β gene polymorphism in Saudi rheumatoid arthritis patients

Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders

Volumn 4, Issue , 2011, Pages 55-63

  Al Rayes, Hannan ^a   Al Swailem, Ramiz ^a   Albelawi, Maysson ^a   Arfin, Misbahul ^a   Al Asmari, Abdulrahman ^a   Tariq, Mohammad ^a  

^a Prince Sultan Military Medical City   (Saudi Arabia)

Author keywords

Polymorphism; Rheumatoid arthritis; Saudi; Tumor necrosis factor

Indexed keywords

GENOMIC DNA; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE DURATION; DISEASE PREDISPOSITION; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; PROGNOSIS; PROMOTER REGION; RHEUMATOID ARTHRITIS; SAUDI ARABIA;

EID: 84860390593     PISSN: 11795441     EISSN: 11795441     Source Type: Journal    
DOI: 10.4137/CMAMD.S6941     Document Type: Article

References (59)

1. Gambhir D, Lawrence A, Aggarwal A, Misra R, Mandal SK, Naik S. Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population. Rheumatol Int. 2010;30(9):1211-7.
2. Brennan FM, Maini RN, Feldmann M. TNF alpha-a pivotal role in rheumatoid arthritis? Br J Rheumatol. 1992;31:293-8.
3. Feldmann M, Brennan FM, Foxwell BM, Mainin RN. The role of TNF alpha and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun. 2001;3:188-99.
4. Beutler B, Cerami A. The biology of cachectin/TNF- a primary mediator of the host response. Annu Rev Immunol. 1989;7:625-55.
5. Nedwin GE, Svedersky LP, Bringman TS, Palladino MA Jr, Goeddel DV. Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta. J Immunol. 1985;135:2492-7.
6. Khanna D, Wu H, Park G, Gersuk V, Gold RH, Nepom GT, et al. Association of tumor necrosis factor α polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort. Arthritis and Rheumatism. 2006;54:1105-16.
7. Chen R, Fang M, Cai Q, Duan S, Lu K, Cheng N, et al. Tumor necrosis factor alpha -308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China. Rheumatol Int. 2007;28:121-6.
8. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997;94:3195-99.
9. Abdallah AN, Cucchi-Mouillot P, Biteau N, Cassaigne A, Haras D, Iron A. Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe regjection. Eur J Immunogenet. 1999; 26:249-55.
10. Panoulas VF, NIkas SN, Smith JP, Douglas KM, Nightingale P, Milionis HJ, et al. Lymphotoxin 252A > G polymorphism is common associates with myocardial infarction in patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:1550-6.
11. Boraska V, Zeggini E, Groves CJ, Rayner NW, Skrabic V, Diakite M, et al. (2009) Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphism with type 1 diabetes in the population of South Croatia. Hum Immunol. 2009;70:195-9.
12. Messer G, Spengler U, Jung MC, Honold G, Biomer K, Pape GR, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991;173:209-19.
13. Abraham LJ, French MAH, Dawkins RL. Polymorphic MHC ancestral hap-lotypes affect the activity of tumor necrosis factor alpha. Clin Exp Immunol. 1993;92:14-8.
14. Takeuchi F, Nabeta H, Hong GH, Kawasugi K, Mori M, Matsuta K, et al. The genetic contribution of the TNFa11 microsatellite allele and the TNFb + 252*2 allele in Japanese RA. Clin Exp Rheumatol. 2005;23: 494-8.
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classifcation of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
16. Perrey C, Turney S, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-a, TNF-P and TGF-P1 gene polymorphisms. Transplant Immunology. 1999;7:127-8.
17. Schallreuter KU, Levenig C, Kuhnl P, Loliger C, Hohl-Tehari M, Berger J. Histocompatability antigens in vitiligo: Hamburg study on 102 patients from Northern Germany. Dermatology. 1993;187:186-92.
18. Savejgaard A, Platz P, Ryder LP. HLA and disease 1982-A survey. Immunol Rev. 1982;70:193-218.
19. Yen JH, Chenm CJ, Tsai WC, et al. Tumor necrosis factor promoter polymorphism in patients with rheumatoid arthritis in Taiwan. J Rheumatol. 2001;28:1788-92.
20. Seki N, Kamizono S, Yamada A, Higuchi T, Matsumoto H, Niiya F, et al. Polymorphism in the 5'-fanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens. 1999;54:194-7.
21. Cvetkovic JT, Wallberg-Jonsson S, Stegmayr B, Rantapaa-Dahlqvist S, Lefvert AK. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes. J Rheumatol. 2002;29:212-9.
22. Ozen S, Alikasifoglu M, Bakkaloglu A, Duzova A, Jarosova K, Nemcova D, et al. Tumor necrosis factor a G -> A -238 and G -> A -308 polymorphisms in juvenile idiopathic arthritis. Rheumatology. 2002;41:223-7.
23. Balog A, Gal J, Gyulai Z, Zsilak S, Mandi Y. Tumor necrosis factor-alpha and heat-shock protein 70-2 gene polymorphisms in a family with rheumatoid arthritis. Acta Microbiol Immunol Hung. 2004;51:263-9.
24. Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Grennan D. Increased frequency of the uncommon allele of a tumor necrosis factor alpha polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers. 1995;12:127-33.
25. Vinasco J, Beraun Y, Nieto A, Fraile A, Mataran L, Pareja E, et al. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigen. 1997; 49:74-8.
26. Rodriguez-Carreon AA, Zuniga J, Hernandez-Pacheco G, Rodriguez- Perez JM, Perez-Hernandez N, Montes de Oca JV, et al. Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J Autoimmun. 2005;24: 63-8.
27. Cuenca J, Cuchacovich M, Perez C, Ferreira L, Aguirre A, Schiattino I, et al. The -308 polymorphism in the tumor necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis. Rheumatology. 2003;42:308-13.
28. Lo SF, Huang CM, Wu MC, Wu JY, Tsai FJ. Lack of association of tumor necrosis factor alpha gene polymorphism in patients with rheumatoid arthritis in central Taiwan. Rheumatol Int. 2003;23:151-3.
29. Pawlik A, Florczak M, Ostanek L, Brzosko M, Brzosko I, Szklarz BG. TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol. 2005;34:22-6.
30. Rezaieyazdi Z, Afshari JT, Sandooghi M, Mohajer F. Tumor necrosis factor a -308 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int. 2007;28:189-91.
31. Ates O, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients. Clin Rheumatol. 2008;27:1243-8.
32. Nemec P, Pavkova-Goldbergova M, Stouracova M, Vasku A, Soucek M, Gatterova J. Polymorphism in the tumor necrosis factor-a gene promoter is associated with severity of rheumatoid arthritis in the Czech population. Clin Rheumatol. 2008;27:59-65.
33. Lee YH, Ji JD, Song GG. Tumor necrosis factor-a promoter -308A/G polymorphism and rheumatoid arthritis susceptibility: a meta-analysis. J Rheumatol. 2007;34:43-9.
34. Ates O, Hatem G, Hamuryudan V, Tpal-Sarikaya A. Tumor necrosis factor - alpha and interleukin-10 gene promoter polymorphism in Turkish rheumatoid arthritis patients. Clin Rheumatol. 2008;27:1243-8.
35. Al-Swailem R, Al-Rayes H, Sobki S, Arfn M, Tariq M. HLA-DRB1 association in Saudi rheumatoid arthritis patients. Rheumatol Int. 2006;26: 1019-24.
36. Criswell LA, Lum RF, Turner KN, Woehl B, Zhu Y, Wang J. The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept. Arthritis Rheum. 2004;50:2750-6.
37. Kula D, Jurecka-Tuleja B, Gubala E, Krawczyk A, Szpak S, Jarzab M. Association of polymorphism of LT alpha and TNF genes with Grave's disease. Folia Histochem Cytobiol. 2001;39:77-8.
38. Medcraft J, Hitman GA, Sachs JA, Whichelow CE, Raafat I, Moore RH. Autoimmune renal disease and tumor necrosis factor beta gene polymorphism. Clin Nephrol. 1993;40:63-8.
39. Zelano G, Lino MM, Evoli A, Settesoldi D, Batocchi AP, Torrente I, et al. Tumor necrosis factor beta gene polymorphisms in myasthenia gravis. Eur J Immunogenet. 1998;25:403-8.
40. Albuquerque RV, Hayden CM, Palmer LJ, Laing IA, Rye PJ, Gibson NA, et al. Association of polymorphisms within the tumor necrosis factor (TNF) genes and childhood asthma. Clin Exp Allergy. 1998;28:578-84.
41. Lu LY, Cheng HH, Sung PK, Tai MH, Yeh JJ, Chen A. Tumor necrosis factor-beta +252A polymorphism is associated with systemic lupus erythematosus in Taiwan. J Formos Med Assoc. 2005;104:563-70.
42. Pandey JP, Takeuchi F. TNF-a and TNF-P gene polymorphisms in systemic sclerosis - a possible link to insulin-dependent diabetes mellitus. Hum Immunol. 1999;60:1128-30.
43. Vasku V, Vasku A, Izakovicova Holla L, Tschoplova S, Kankova K, Benakova N, et al. Polymorphisms in infammation genes (angiotensino-gen, TAP1 and TNF-beta) in psoriasis. Arch Dermatol Res. 2000;292: 531-4.
44. Mugnier B, Balandraud N, Darque A, Roudier C, Roudier J, Reviron D. Polymorphism at position -308 of the tumor necrosis factor a gene infuences outcome of infiximab therapy in rheumatoid arthritis. Arthritis and Rheum. 2003;48:1849-52.
45. Guis S, Balandraud N, Bouvenot J, Auger I, Toussirot E, Wendling D, et al. (2007) Infuence of -308A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis. Arthritis Rheum. 2007;57:1426-30.
46. Seitz M, Wirthmuller U, Moller B, Villiger PM. The -308 tumor necrosis factor-α gene polymorphism predicts therapeutic response to TNFα-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology. 2007;46:93-6.
47. Wingerchuk D, Liu Q, Sobell J, Sommer S, Weinshenker BG. A population-based case-control study of the tumor necrosis factor alpha -308 polymorphism in multiple sclerosis. Neurology. 1997;49:626-8.
48. Milner CR, Craig JE, Hussey ND, Norman RJ. No association between the -308 polymorphism in the tumor necrosis factor α (TNF-α) promoter region and polycystic ovaries. Mol Hum Reprod. 1999;5:5-9.
49. Cuenca J, Perez C, Aguirre A, Schiattino I, Aguillon JC. Genetic polymorphism at position -308 in the promoter region of the tumor necrosis factor (TNF): Implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population. Biol Res. 2001;34:237-41.
50. Lee SC, Pu YB, Thomas GN, Lee ZSK, Tomlinson B, Cockram CS, et al. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism. 2000;49:1021-4.
51. Rasmussen SK, Urhammer SA, Jensen JN, Hansen T, Borch-Johnsen K, Pedersen O. The -238 and -308 G.A polymorphisms of the tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. J Clin Endocrinol Metab. 2000;85:1731-4.
52. Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, Hazes JM, et al. Tumor necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol. 1997;36:516-21.
53. Keatings VM, Cave SJ, Henry MJ, Morgan K, O'Connor CM, Fitzgeral MX, et al. A polymorphism in the tumor necrosis factor-α gene promoter region may predispose to a poor prognosis in COPD. Chest. 2000;118:971-5.
54. Maury CP, Liljestrom M, Laiho K, Tiitinen S, Kaarela K, Hurme M. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Arthritis Rheum. 2003;48:3068-76.
55. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, et al. Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality. JAMA. 1999;282:561-8.
56. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer Zum Buschenefelde KH, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol. 1998;11:579-82.
57. Ishii T, Hirose H, Saito I, Nishikai K, Maruyama H, Saruta T. Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men. Metabolism. 2000;49:1616-8.
58. Rosmond R, Chagnon M, Bouchard C, Bjorntorp P. G-308 A polymorphism of the tumor necrosis factor alpha gene promoter and salivary cortisol secretion. J Clin Endocrinol Metab. 2001;86:2178-80.
59. Conway DJ, Holland MJ, Bailey RL, et al. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun. 1997;65:1003-6.